Protein Biomarkers Associated with Dulaglutide and Cardiovascular Events in REWIND

被引:0
|
作者
Wilson, Jonathan M.
Pare, Guillaume
Lee, Shun Fu
Colhoun, Helen M.
Qian, Hui-Rong
Pirro, Valentina
Hoover, Anastasia
Lakshmanan, Mark
Ruotolo, Giacomo
Duffin, Kevin L.
Gerstein, Hertzel C.
机构
关键词
D O I
10.2337/db22-725-P
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
725-P
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Metabolite Biomarkers and Cardiovascular Events in REWIND: A Post Hoc Analysis
    Pirro, Valentina
    Pare, Guillaume
    Lee, Shun Fu
    Colhoun, Helen M.
    Lin, Yanzhu
    Wilson, Jonathan M.
    Qian, Hui-Rong
    Hoover, Anastasia
    Duffin, Kevin L.
    Gerstein, Hertzel C.
    DIABETES, 2022, 71
  • [2] Exploring Potential Mediators of the Cardiovascular Benefit of Dulaglutide in REWIND
    Colhoun, Helen M.
    Hasenour, Clinton
    Riddle, Matthew C.
    Branch, Kelley
    Konig, Manige
    Atisso, Charles
    Lakshmanan, Mark
    Mody, Reema
    Gerstein, Hertzel C.
    DIABETES, 2020, 69
  • [3] Exploring potential mediators of the cardiovascular benefit of dulaglutide in REWIND
    Gerstein, H.
    Colhoun, H.
    Riddle, M.
    Branch, K.
    Konig, M.
    Atisso, C.
    Lakshmanan, M.
    Mody, R.
    Hasenour, C.
    DIABETOLOGIA, 2020, 63 (SUPPL 1) : S74 - S74
  • [4] Design and baseline characteristics of participants in the Researching cardiovascular Events with a Weekly INcretin in Diabetes (REWIND) trial on the cardiovascular effects of dulaglutide
    Gerstein, Hertzel C.
    Colhoun, Helen M.
    Dagenais, Gilles R.
    Diaz, Rafael
    Lakshmanan, Mark
    Pais, Prem
    Probstfield, Jeffrey
    Riddle, Matthew C.
    Ryden, Lars
    Xavier, Denis
    Atisso, Charles M.
    Avezum, Alvaro
    Basile, Jan
    Chung, Namsik
    Conget, Ignacio
    Cushman, William C.
    Franek, Edward
    Hancu, Nicolae
    Hanefeld, Markolf
    Holt, Shaun
    Jansky, Petr
    Keltai, Matyas
    Lanas, Fernando
    Leiter, Lawrence A.
    Lopez-Jaramillo, Patricio
    Cardona-Munoz, Ernesto G.
    Pirags, Valdis
    Pogosova, Nana
    Raubenheimer, Peter J.
    Shaw, Jonathan
    Sheu, Wayne H-H.
    Temelkova-Kurktschiev, Theodora
    DIABETES OBESITY & METABOLISM, 2018, 20 (01): : 42 - 49
  • [5] Biomarker Changes Associated With Both Dulaglutide and Cardiovascular Events in the REWIND Randomized Controlled Trial: A Nested Case-Control Post Hoc Analysis
    Gerstein, Hertzel C.
    Lee, Shun-Fu
    Pare, Guillaume
    Bethel, M. Angelyn
    Colhoun, Helen M.
    Hoover, Anastasia
    Lakshmanan, Mark
    Lin, Yanzhu
    Pirro, Valentino
    Qian, Hui-Rong
    Ruotolo, Giacomo
    Ryden, Lars
    Wilson, Jonathan M.
    Duffin, Kevin L.
    DIABETES CARE, 2023, 46 (05) : 1046 - 1051
  • [6] Total cardiovascular or fatal events in people with type 2 diabetes and cardiovascular risk factors treated with dulaglutide in the REWIND trail: a post hoc analysis
    Dagenais, Gilles R.
    Ryden, Lars
    Leiter, Lawrence A.
    Lakshmanan, Mark
    Dyal, Leanne
    Probstfield, Jeffrey L.
    Atisso, Charles Messan
    Shaw, Jonathan E.
    Conget, Ignacio
    Cushman, William C.
    Lopez-Jaramillo, Patricio
    Lanas, Fernando
    Munoz, Ernesto German Cordona
    Pirags, Valdis
    Pogosova, Nana
    Basile, Jan
    Sheu, Wayne H. H.
    Temelkova-Kurktschiev, Theodora
    Raubenheimer, Peter J.
    Keltai, Matyas
    Hall, Stephanie
    Pais, Prem
    Colhoun, Helen M.
    Riddle, Matthew C.
    Gerstein, Hertzel C.
    CARDIOVASCULAR DIABETOLOGY, 2020, 19 (01)
  • [7] Total cardiovascular or fatal events in people with type 2 diabetes and cardiovascular risk factors treated with dulaglutide in the REWIND trail: a post hoc analysis
    Gilles R. Dagenais
    Lars Rydén
    Lawrence A. Leiter
    Mark Lakshmanan
    Leanne Dyal
    Jeffrey L. Probstfield
    Charles Messan Atisso
    Jonathan E. Shaw
    Ignacio Conget
    William C. Cushman
    Patricio Lopez-Jaramillo
    Fernando Lanas
    Ernesto German Cordona Munoz
    Valdis Pirags
    Nana Pogosova
    Jan Basile
    Wayne H. H. Sheu
    Theodora Temelkova-Kurktschiev
    Peter J. Raubenheimer
    Matyas Keltai
    Stephanie Hall
    Prem Pais
    Helen M. Colhoun
    Matthew C. Riddle
    Hertzel C. Gerstein
    Cardiovascular Diabetology, 19
  • [8] Biomarkers associated with cardiovascular events in CKD
    Helene Myrvang
    Nature Reviews Nephrology, 2012, 8 (9) : 493 - 493
  • [9] Exploring potential mediators of the cardiovascular benefit of dulaglutide in type 2 diabetes patients in REWIND
    Manige Konig
    Matthew C. Riddle
    Helen M. Colhoun
    Kelley R. Branch
    Charles M. Atisso
    Mark C. Lakshmanan
    Reema Mody
    Sohini Raha
    Hertzel C. Gerstein
    Cardiovascular Diabetology, 20
  • [10] Exploring potential mediators of the cardiovascular benefit of dulaglutide in type 2 diabetes patients in REWIND
    Konig, Manige
    Riddle, Matthew C.
    Colhoun, Helen M.
    Branch, Kelley R.
    Atisso, Charles M.
    Lakshmanan, Mark C.
    Mody, Reema
    Raha, Sohini
    Gerstein, Hertzel C.
    CARDIOVASCULAR DIABETOLOGY, 2021, 20 (01)